John W. Hlywak, Jr. (Investors) Jay Higham(Physician and Media)
Senior Vice President & CFO President & COO
IntegraMed America, Inc. IntegraMed America, Inc.
(914) 251-4143 (914) 251-4127
email: jhlywak@integramed.com email: jayhigham@integramed.com
---------------------- ------------------------
Web Address: http://www.integramed.com
-------------------------
IntegraMed Announces Errant Reuters Report
Purchase, NY, December 2, 2004 -- IntegraMed America, Inc. (Nasdaq: INMD)
learned that an errant report was made November 29, 2004 by Reuters that listed
IntegraMed's symbol (INMD) related to a research report that indicated inhaling
a saline solution could prevent the spread of diseases. The intended symbol for
the Reuters report is IMDC. IntegraMed has no information why this error
occurred.
About IntegraMed America, Inc.
IntegraMed, based in Purchase, NY offers products and services to patients,
providers and payors focused on the $2 billion fertility industry. IntegraMed
provides business services to a national network of fertility centers;
distributes pharmaceutical products and treatment financing programs directly to
consumers; and operates http://www.integramed.com, a leading fertility portal.
Statements contained in this press release that are not based on historical
fact, including statements concerning future results, performance, expectations
and expansion of IntegraMed America are forward-looking statements that may
involve a number of risks and uncertainties. Actual results may differ
materially from the statements made as a result of various factors, including,
but not limited to, the risks associated with the Company's ability to finance
future growth; the loss of significant business service contract(s);
profitability at Reproductive Science Centers serviced by IntegraMed America;
changes in insurance coverage, government laws and regulations regarding health
care or managed care contracting; and other risks, including those identified in
the Company's most recent Form 10-K and in other documents filed by the Company
with the U.S. Securities and Exchange Commission. All information in this press
release is as of December 2, 2004 and IntegraMed undertakes no duty to update
this information.
####